Page 2
M a r k et < D a t a> S co r e
Volume 1, Issue 1
TEA
MARKETER COMPLETES FINANCING
Royal Gypsy Tea Co., also known as Zhena's tea, successfully raised $500,000 via an equity private placement. Seven investors participated to the non-brokered offering. The company raised an estimated $7.4 million in equity since 2009. Tiesta Tea an up and coming competitor raised close to $1 million this month. Zhena's Gypsy Tea is a pro-active purpose brand offering a selection of fair trade and socially responsible organic and biodynamic
$500,000
EQUITY
To Discuss Content Opportunities, please contact [email protected] To Discuss Report Opportunities, please contact [email protected] For White Label or Advertising Opportunities or to Subscribe to our Newsletter, please contact [email protected]
teas and herbs. The company aims at making a difference in people's lives by offering only premium teas that benefit consumer's health, the health of the planet and the livelihood of its suppliers. The company, located in Commerce CA, was founded by Zhena Muzyka in 2009 and is lead by Sean Ryan (CEO) and Paula Muesse (COO and CFO). The board of directors include Scott Sipprelle and Zhena Muzyka.
Private Placement Funding Intelligence
"GOOD" $400,000
VIRUS MAKER IN THE MARKET WITH A MEZZANINE OFFERING
agricultural, food & water, industrial, pharmaceutical, and defense markets. It received an EPA registration for its’ AgriPhage bacteria-control product line. The company, headquartered in Sandy UT, is lead by Justin Rieber (President and CEO).
Market Data Score (MDS) provides research and news on emerging companies and entities active on the US private placement market. MDS is a key solution for investors and entities that need to keep their finger on the pulse of the SMB market and connect with startups. MDS was founded by a team of highly experienced professionals who realized small private placement financing transactions are not well covered and researched by traditional media and data providers. The team has a combined 75years in the financial services and marketing industry What makes us different?
OmniLytics, Inc. raised 50% of its $400,000 mezzanine private placement from one investor. The company placed an estimated $700,000 in mezzanine security since 2009. The offering will remain open for a year during which at most four investors will be sought after.
OmniLytics, Inc. develops bacteriophage, i.e. good viruses that eat specific bacteria, as a natural solution for infectious disease control. The company's bacteriophage technology is leveraged for the research and development of bacteriophage solutions for pathogen control in the
CLOTHING
E - R E TA I L E R A N N O U N C E D F I R S T CL ?4R??C3?UT?E??ddU$??p??V??6??F???r6??&?6VB&V???'?C???WB?b?W?V7FVBC3?WV?G??ffW&??r?Gv???fW7F?'2'F?6?FVBF?F?R????'&??W&VBf???6??r?F??2?2F?Rf?'7B???v?U2&?fFR?ffW&??r???F?FVB'?F?R6?????F?R6????6???76???2??Vf7GW&W'2??6FVB??F?RU2F?&?GV6R6??F?W2F?W?FW6?v?f?"?V??F?RvV'6?FR?ffW'26??'G2??G2??V6?vV"2vV??2w&????r7W?W2??V?????6FVB??&?V?v??2?v2f?V?FVB??#?'?&'F??7G&v??7&VF?fRF?&V7F?"???W7F??6&W??4d???WFW"??F?2?7W?6?????BV?6????"?&WF???B?&?WF??r??(
"(
"(
??F?RFWF??B'&VGF??b?W"FF?W"&?&?WF'??Ww2b&W6V&6??W"???FWF???6?2?bF?R&?fFR6V7F?"gV?F??r7F?f?G???